Fort Point Capital Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,300
Closed -$234K 171
2017
Q3
$234K Buy
+1,300
New +$181K 0.11% 110

Fort Point Capital Partners's KITE Position: Q4 2017 in Review

Fort Point Capital Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,300 shares — an estimated $234K sold.

Fort Point Capital Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $234K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Fort Point Capital Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Fort Point Capital Partners sold 1,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $234K.
  • Fort Point Capital Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Fort Point Capital Partners's Kite Pharma, Inc. position peaked at $234K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Fort Point Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.